Challenges of Diphtheria Toxin Detection

Area of Science:

• Microbiology
• Infectious Diseases
• Diagnostic Technology

Background:

• Diphtheria toxin (DT) is the primary virulence factor for *Corynebacterium diphtheriae*, *C. ulcerans*, and *C. pseudotuberculosis*, necessitating accurate detection methods.
• The Elek test, established in 1888, is the traditional diagnostic standard for DT detection, despite limitations in antitoxin availability and declining expertise.
• Emerging *Corynebacterium* species capable of producing DT underscore the ongoing need for reliable diagnostic tools.

Purpose of the Study:

• To review the diagnostic methods for diphtheria toxin (DT) detection, highlighting the limitations of current practices.
• To explore advancements in DT detection assays, focusing on their potential for improved clinical application.
• To assess the diagnostic utility of novel point-of-care testing (POCT) strategies for DT and related *Corynebacterium* infections.

Main Methods:

• Review of historical and contemporary methods for diphtheria toxin detection.
• Evaluation of the diagnostic performance and limitations of the Elek test.
• Analysis of emerging rapid diagnostic technologies, including immunochromatographic strip assays (ICS), lateral flow immunoassay (LFIA), loop-mediated isothermal amplification (LAMP), and biosensors.

Main Results:

• The Elek test, while foundational, faces challenges due to antitoxin scarcity and reduced laboratory experience, particularly in low-prevalence settings.
• New assays like ICS and LFIA for toxin detection, LAMP for *tox* gene detection, and biosensors offer promising alternatives.
• These novel methods demonstrate potential for rapid, point-of-care (POCT) applications, addressing the need for faster and more accessible diagnostics.

Conclusions:

• Accurate detection of diphtheria toxin remains critical for diagnosing various *Corynebacterium* infections.
• Despite its historical significance, the Elek test's utility is challenged by practical limitations.
• Emerging rapid diagnostic technologies present a significant advancement, offering potential for timely and efficient point-of-care testing for diphtheria and related diseases.